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Abstract: A tethered ruthenium-TsDPEN catalyst is employed for the facile catalytic asymmetric 
reduction of α-phthalimyl-α’-ketoethers under mild conditions. Leveraging exclusively on the 
contrasting electronic densities on the heteroatoms, a series of enantioenriched phthalimyl ether 
alcohols can be obtained in generally good stereoselectivities from this challenging class of substrate. 
Subsequent transformation into highly valuable chiral β-amino alcohols is demonstrated to take place 
without significant losses in yield and optical purity. 
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1. Introduction 
 
The demand for enantiomerically enriched compounds notably in the pharmaceutical and 
agricultural industries has precipitated accelerated advancements in the field of asymmetric catalysis in 
recent years,[1] the benefits of which include improved atom economy, reduced environmental impact 
and as an approach to circumvent the high cost and/or availability of chiral starting materials.[2] 
 
 An integral component in a myriad of compounds, the chiral β-amino alcohol backbone can be 
found in pharmaceuticals,[3] natural products[4] (Figure 1) peptidomimetics[5] and perfumes.[6] Moreover, 
β-amino alcohols also function as resolving agents, ligands and auxiliaries in synthetic chemistry.[7] Yet, 
the conventional preparation of optically active β-amino alcohols is not straightforward with traditional 
methodologies requiring cumbersome multi-step synthetic transformations.[4] Having in recent years 
established a robust catalytic system employing tethered ruthenium-TsDPEN complexes (1) for the 
asymmetric reduction of several substrate classes, our  
 
H
NArO
OH
Ar = 1-Napthyl,  (S)-Propranolol
Ar = m-methylphenyl, (S)-Toliprolol
Ar = o-methoxylphenyl, (S)-Moprolol
i-Pr
As medicines
N
H
N
N
H
O
CONH2
O Bn
OH
N
H
H
CONHt-Bu
Saquinavir
-blockers
Anti-viral: HIV protease inhibitor
N
H
OH
NH OH
NH2
Nitric oxide synthease (NOS) inhibitor
Natural Products
HO
NH2
OH
(  )12
Sphingosine
N
H
O
N
NOH
O
Febrifugine
N
H
OH OH
OH
Swainsonine  
 
Figure 1. Selected examples of medicines and natural products bearing the vicinal amino alcohol 
backbone. 
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Scheme 1. Favorable electronic directing effects affording products of excellent optical purities. 
 
group and others have made considerable progress with conventional ketones and imines.[8] The 
favourable electronic interaction (edge-face) between the electronically-rich groups in the substrate 
(aromatic, alkyne) and the electron deficient η6-arene ring of the catalyst is critical for achieving 
excellent enantiocontrol (Scheme 1).[9] As such, there exists an abundance of research on the 
asymmetric reduction of aromatic ketones and imines as they generally produce products with excellent 
enantioselectivities. Alkyl ketones bearing heteroatoms on the α-positions however have rarely been 
studied and in these cases, molecular hydrogen under high pressures is employed.[10]  
 
 While the direct asymmetric reduction of α-amino-α’-ether ketones would afford the desired β-
amino alcohols, it was apparent that this approach would produce undesirable optical purities since 
enantiocontrol is postulated to be controlled predominantly by the differential electronic densities of 
the heteroatoms flanking the keto group although steric effects and dispersion forces also make a 
significant contribution.[9c]  Inspired by the concept of employing protecting-activating groups in the 
synthesis of carbohydrates,[11] amino acids/peptides,[12] macrocycles[13] as well as in 
hydrophosphination,[14] the phthalimyl moiety was selected as a masked surrogate for the amino 
functionality owing to its low cost, stability and more importantly, its ease of deprotection and the 
ability to negate the high electronic density on the nitrogen atom. This protecting group has also been 
shown to be compatible in the ATH of acetophenone derivatives.[15] Herein, we report the facile 
asymmetric transfer hydrogenation (ATH) of α-phthalimyl-α’-ketoethers 2 under mild conditions and 
the subsequent transformation into chiral β-amino alcohols 3 (Scheme 2); the latter serving as invaluable 
building blocks towards prized compounds such as β-blockers as illustrated in Figure 1. 
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Scheme 2. Synthetic pathway to optically active β-amino alcohols. 
 
 
2. Experimental section 
 
Analytical grade solvents were used directly without further purification as purchased from 
commercial sources: chloroform, acetone and tetrahydrofuran from VWR Chemicals; toluene, 
acetonitrile and concentrated sulphuric acid from Fischer Scientific; dichloromethane and 1,2-
dichloroethane from Sigma Aldrich. Chiral tethered ruthenium catalyst (R,R)-1a supplied by Johnson 
Matthey and (S)-oxiranylanisole [97% sum of enantiomers] and AD-mix-α from Sigma Aldrich was 
used directly without further purification. Flash chromatography on silica was conducted on Sigma 
Aldrich silica gel (technical grade, pore size 60Å, 230-400 mesh, 40-63 µm particle size). Room 
temperature is defined to be approximately 20 oC. 
NMR spectra were recorded on Bruker Avance III HDF 400 and 500 spectrometers. 1H NMR 
spectra chemical shifts were reported in δ ppm relative to chloroform (δ = 7.26 ppm) or 
tetramethylsilane (δ = 0.00 ppm). Multiplicities were given as: s (singlet), d (doublet), t (triplet), q 
(quartet) and m (multiplet). The number of protons (n) for a given resonance was indicated by nH while 
coupling constants were reported as J value in Hertz (Hz). 13C NMR spectra chemical shifts were 
recorded relative to solvent resonance (CDCl3: δ = 77.26 ppm). Optical rotations of optically active 
alcohols were measured in the specified solution using a 2 dm cell with an Optical Activity Ltd. AA-
1000 polarimeter. Chiral HPLC was performed on a Hewlett Packard 1050 HPLC machine 
incorporating a Diacel CHIRAPAK® IA, IC or Diacel CHIRALCEL OD-H column. 
 
Detailed procedures for the syntheses of all starting materials can be found in the Supporting 
Information. 
 
2.1 Ru/TsDPEN 1a catalyzed asymmetric transfer hydrogenation of 2 and 5 
 
To a nitrogen flushed Schlenk tube was charged with ketone 2,5 (0.10 - 0.20 mmol) and catalyst 
(R,R)-1a (3 mol%) before the addition of equivalent volumes of chloroform and 5:2 formic 
acid/triethylamine solution (TEAF) such that the total concentration of the ketone is 1M (unless 
otherwise stated). Reaction is allowed to stir overnight (>15 hrs) at room temperature (ca. 20 oC) before 
quenching with excess saturated sodium bicarbonate solution and subsequently extracting the mixture 
with ethyl acetate (2 x 3 mL). The combined organic layers were concentrated then purified by flash 
chromatography on silica to afford the desired chiral alcohols. 
 
2.2 Deprotection of phthalimyl alcohol (S)-3a 
 
Phthalimyl alcohol (S)-3a (294 mg, 0.99 mmol, 1 equiv.), hydrazine hydrate (0.29 mL, 5.94 
mmol, 6 equiv.) was added to ethanol (40 mL) and the solution refluxed for 2 hours. Consequently, the 
setup was cooled in ice water and white solid formed were filtered off by Celite and the cake washed 
with excess ethyl acetate. The filtrate was subject to solvent strip under reduced pressure and the residue 
purified by Kugelrohr distillation to afford (S)-4a (white solid, 142 mg, 86%). 
 
3. Results and discussion 
 
We began our study with the optimization of the ATH reaction using 2-(2-oxo-3-
phenoxypropyl)isoindoline-1,3-dione 2a as the prototypical substrate. A variety of conditions were 
examined ranging from the employed solvents, temperatures, catalyst (loading), formic acid-
triethylamine molar ratio; the results are presented in Table 1. The catalyst loading was initially 
screened, with an increase in loading affording a slightly improved enantiomeric excess (ee) (Table 1, 
entries 1-2). Subsequently, a range of solvents were studied and this study revealed that chloroform was 
the ideal solvent for the reaction (Table 1, entries 2-8). It was gratifying to note a considerable 
improvement of ee from 61 to 73% with the employment of a lowered temperature (Table 1, entries 
2,9). Conversely, substituting the catalyst with a 4-methoxy analog 1b or varying the formic 
acid/triethylamine ratio both produced less desirable outcomes (Table 1, entries 10-11). The absolute 
configuration of the newly formed chiral centre was established by the treatment of phthalimide with 
commercially available (S)-oxiranylanisole to give (S)-3a.[16] Subsequent comparison of HPLC data 
with that obtained in the ATH reactions confirmed our hypothesis that it is indeed the electronically 
richer oxygen heteroatom in 2a interacting with the electron deficient η6-arene ring of the catalyst 
(Scheme 3). This dominant directing effect thus affords optically enriched phthalimyl alcohol 3a with 
the expected R configuration. 
With the optimal conditions established, we screened a variety of substrates bearing various 
functionalities and the outcomes are illustrated in Table 2. Owing to the enhanced understanding of the 
catalytic mechanism whereby the catalyst prefers electronically richer elements adjacent to its aromatic 
ring, ketones bearing alkyl ethers (Table 2, entries 10-15) generally outperform aryl ether analogs 
(Table 2, entries 1-7) in terms of optical purities of the alcohol derivatives. On the contrary,  
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Scheme 3. Control of absolute configuration during reduction of substrate 2a. 
 
substituents containing electronic withdrawing moieties afforded products with significantly lower ees 
(Table 2, entries 8-9). It is noteworthy that the 2-methoxy phenyl substrate (Table 2, entry 6) surpassed 
the meta and para counterparts (Table 2, entries 10-12), while the 2,6-dimethoxyphenyl analog afforded 
the best enantiomeric excess at 90% (Table 2, entry 7). While it is expected that the para-methoxy 
substrate 2d would give a better enantioselectivity as compared to its meta analog 2e aspredicted by 
Hammett’s constants (σp = -0.27, σm = 0.12),[17] the enhanced enantioselectivities with ortho substituents 
(2f-g) could be postulated to be due to steric factors. In consideration of enantioenriched halohydrins 
being fundamental building blocks and target intermediates towards biologically active compounds,[18] 
we were keen on substituting the ether functionality in 2 with a halogen moiety, by virtue of the latter 
being a readily substituted group for further manipulations. Correspondingly, we studied the ATH of 2-
(3-chloro-2-oxopropyl)isoindoline-1,3-dione 5 to give optically active chlorohydrin 6 (Scheme 4). In 
spite of the excellent yield obtained, enantiocontrol proved to be challenging, suggesting that a single 
chlorine atom cannot provide a directing effect similar to that of the alkoxy and aryloxy-groups in 2. 
Despite the poor ee, to the best of our knowledge, this is one of the few reported examples of the 
asymmetric reduction of ketones bearing the 1-chloro-2-propanone backbone. Asymmetric transfer 
hydrogenation, in good yield and ee of structurally related N-protected (3S)-3-amino-1-chloro-4-
phenyl-2-butanones with analogous Rh(III) complexes has been reported[19] however the majority of 
the studies primarily involving α-chloromethyl aromatic ketones as substrates.[20] 
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Scheme 4. Preparation of optically active halohydrin via ATH. 
 
To demonstrate the versatility of the phthalimyl moiety as an excellent surrogate for the amino 
group, enantiopure (S)-3a was treated with hydrazine to give amino alcohol (S)-4a in excellent yield 
with no observable loss in enantiomeric purities (Scheme 5).[16] Derivatives of compound 4 can be 
further converted into a series of β-blockers (Figure 1), thus offering an attractive alternative synthetic 
path for their preparation. 
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Scheme 5. Facile deprotection of phthalimyl alcohol with no observable loss in optical purity. 
 
4. Conclusions 
 
In conclusion, the challenging catalytic asymmetric transfer hydrogenation of α-phthalimyl-α’-
ketoethers has been achieved under mild conditions, affording phthalimyl alcohols in good to excellent 
yields with a range of enantiomeric excesses. The effects of differential electronic densities on the 
heteroatoms in influencing enantioselectivity are elucidated in this study, contributing towards an 
improved understanding to the mechanisms of reduction by tethered Ru(II) catalysts. More importantly, 
the obtained alcohols can be readily deprotected to give optically active amino alcohols which are 
invaluable building blocks to a variety of prized compounds. 
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Table 1. Optimization of reaction conditions for the catalytic ATH of 2-(2-oxo-3-
phenoxypropyl)isoindoline-1,3-dione 2a[a] 
ON OPh
O
O
2a
+ HCO2H/Et3N
(R,R)-1
solvents
OH
N OPh
O
O
3a
*
Ru
NH
TsN
Ph
Ph
Cl
(R,R)-1
R=H, 1a
R=OMe, 1b
R
 
Entry 
Catalyst / Loading 
(mol%) 
Temperature 
(oC) 
HCO2H:Et3N[b] Solvent Yield[c] (%) ee[d] (%) 
1 1a / 1 40 5:2 CHCl3 77 59 
2 1a / 3 40 5:2 CHCl3 72 61 
3 1a / 5 40 5:2 THF 48 48 
4 1a / 5 40 5:2 toluene 51 52 
5 1a / 3 40 5:2 MeCN 78 50 
6 1a / 3 40 5:2 MeNO2 93 55 
7 1a / 3 40 5:2 DCM 71 54 
8 1a / 3 40 5:2 
1,2-
EDC 
91 57 
9[e] 1a / 3 rt (20) 5:2 CHCl3 91 73 
10[e] 1a / 3 rt (20) 3:2 CHCl3 82 57 
11[e] 1b / 3 rt (20) 5:2 CHCl3 90 56 
[a] Reaction conditions: ca. 0.15 mmol 2a, [2a]=1M (in equal volumes of formic acid/triethylamine solution and added 
solvent), >15hrs reaction time; [b] Molar ratio; [c] Isolated yield; [d] Enantiomeric excess as determined by HPLC; [e] Excess 
solvents are added: [2a]=0.50M. 
 
 
Table 2. Substrate table for the catalytic ATH of α-phthalimyl-α’-ketoethers 2[a]  
 
O
N OR
O
O
2
+ HCO2H/Et3N
(5:2)
(R,R)-1a [3mol%] OH
N OR
O
O
(R)-3
20 oC, CHCl3
 
Entry Substrate R Product Yield[b] (%) ee[c] (%) 
1[d] 2a phenyl 3a 91 73 
2[e] 2b 2-napthyl 3b 92 76 
3 2c 4-MeC6H4 3c 95 78 
4 2d 4-MeOC6H4 3d 88 75 
5[d] 2e 3-MeOC6H4 3e 88 71 
6 2f 2-MeOC6H4 3f 92 82 
7 2g 2,6-MeOC6H3 3g 93 90 
8[d] 2h 4-PhC6H4 3h 89 66 
9[f] 2i 4-BrC6H4 3i 95 58 
10 2j methyl 3j 90 77 
11 2k isopropyl 3k 76 79 
12[d] 2l allyl 3l 84 78 
13[d] 2m propargyl 3m 89 81 
14[d] 2n benzyl 3n 99 76 
15[d] 2o furfuryl 3o 86 84 
[a] Reaction conditions: ca. 0.10-0.20 mmol 2, [2]=1M (in equal volumes of formic acid/triethylamine solution and added 
solvent), >15hrs reaction time; [b]  Isolated yield; [c] Enantiomeric excess as determined by HPLC; Due to poor solubility of the 
substrate, excess solvents are added:  [d] [2]=0.50M, [e] [2]=0.067M, [f] [2]=0.25M 
